Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lynn Henry

Showing results (41-50 of 195) with videos related to

Pageof 20
Sort By:
Nature Reviews. Cancer|October 13, 2006
Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinantsVered Stearns, Bryan Schneider, N Lynn Henry, et al.
Breast Cancer Research and Treatment|January 23, 2016
Incidental radiologic findings at breast cancer diagnosis and likelihood of disease recurrenceJoel M Brothers, Kelley M Kidwell, Richard K J Brown, et al.
The American Journal of Psychiatry|October 3, 2008
Drug interactions and pharmacogenomics in the treatment of breast cancer and depressionN Lynn Henry, Vered Stearns, David A Flockhart, et al.
Clinical Pharmacology and Therapeutics|December 7, 2023
Risk of Toxicity From Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant AllelesJavier Granados, Amy L Pasternak, N Lynn Henry, et al.
JCO Oncology Practice|March 3, 2022
Survey of US Medical Oncologists' Practices and Beliefs Regarding <i>DPYD</i> Testing Before Fluoropyrimidine ChemotherapyKyoin Koo, Amy L Pasternak, N Lynn Henry, et al.
Physiological Genomics|December 8, 2017
Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancerJacqueline M Dempsey, Jingyue Xi, N Lynn Henry, et al.
The Oncologist|December 10, 2013
Prediction of postchemotherapy ovarian function using markers of ovarian reserveN Lynn Henry, Rong Xia, Anne F Schott, et al.
Breast Cancer Research and Treatment|January 9, 2021
Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancerMei Wei, Xuechen Wang, Danielle N Zimmerman, et al.
Breast Cancer Research and Treatment|November 13, 2022
Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patientsElizabeth Joyce, Grant Carr, Sidi Wang, et al.
JCO Oncology Practice|August 27, 2024
Targeted Therapies, Sequencing Strategies, and Beyond in Metastatic Hormone Receptor-Positive Breast Cancer: ASCO Guideline Clinical InsightsIgor Makhlin, Lesley Fallowfield, N Lynn Henry, et al.
Pageof 20

Showing results (41-50 of 195) with videos related to

Sort By:
Pageof 20
Nature Reviews. Cancer|October 13, 2006
Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinantsVered Stearns, Bryan Schneider, N Lynn Henry, et al.
Breast Cancer Research and Treatment|January 23, 2016
Incidental radiologic findings at breast cancer diagnosis and likelihood of disease recurrenceJoel M Brothers, Kelley M Kidwell, Richard K J Brown, et al.
The American Journal of Psychiatry|October 3, 2008
Drug interactions and pharmacogenomics in the treatment of breast cancer and depressionN Lynn Henry, Vered Stearns, David A Flockhart, et al.
Clinical Pharmacology and Therapeutics|December 7, 2023
Risk of Toxicity From Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant AllelesJavier Granados, Amy L Pasternak, N Lynn Henry, et al.
JCO Oncology Practice|March 3, 2022
Survey of US Medical Oncologists' Practices and Beliefs Regarding <i>DPYD</i> Testing Before Fluoropyrimidine ChemotherapyKyoin Koo, Amy L Pasternak, N Lynn Henry, et al.
Physiological Genomics|December 8, 2017
Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancerJacqueline M Dempsey, Jingyue Xi, N Lynn Henry, et al.
The Oncologist|December 10, 2013
Prediction of postchemotherapy ovarian function using markers of ovarian reserveN Lynn Henry, Rong Xia, Anne F Schott, et al.
Breast Cancer Research and Treatment|January 9, 2021
Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancerMei Wei, Xuechen Wang, Danielle N Zimmerman, et al.
Breast Cancer Research and Treatment|November 13, 2022
Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patientsElizabeth Joyce, Grant Carr, Sidi Wang, et al.
JCO Oncology Practice|August 27, 2024
Targeted Therapies, Sequencing Strategies, and Beyond in Metastatic Hormone Receptor-Positive Breast Cancer: ASCO Guideline Clinical InsightsIgor Makhlin, Lesley Fallowfield, N Lynn Henry, et al.
Pageof 20